A
Aprea Therapeutics, Inc. (APRE)
NCM – Real Time Price. Currency in USD
0.79
+0.00 (0.04%)
At close: Jun 26, 2026, 4:00 PM EDT
0.79
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.79
+0.00 (0.04%)
At close: Jun 26, 2026, 4:00 PM EDT
0.79
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Cash reserves $46.5M barely cover the upcoming debt maturities $0.0
Total current assets $47.2M exceed Total current liabilities $5.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.92 | 6.05 | 10 | |
| Quick ratio | 8.92 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 583K | 2M | 286K | 123K |
| Gross Profit | -186K | 576K | 1M | 264K | 102K |
| Operating Income | -37M | -15M | -14M | -13M | -13M |
| Net Income | -113M | -14M | -13M | -13M | -12M |
| EBITDA | -37M | -15M | -14M | -13M | -13M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 114.21 | 65.57 | 10 |
| Next quarter | 16539.61 | 60.64 | 10 |
| Current year | 274.44 | 64.38 | 10 |
| Next year | 111.5 | 4.73 | 7.0 |
| Weighted average score | 9.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -33.88 | 31.25 | 10.11 | 4.8 |
| Y/Y | -99.99 | 16.39 | 66.67 | 24.08 | 7.5 |
| 3y average | 358.55 | 33.13 | 50.86 | 15.11 | 9.8 |
| 5y average | 614.73 | -14.68 | 17.69 | 17.77 | 7.3 |
| Weighted average score | 7.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |